**Exhibit
      31.1**








**CERTIFICATION
      PURSUANT TO**


**RULE
      13A-14 OF THE SECURITIES EXCHANGE ACT OF 1934,**


**AS
      ADOPTED PURSUANT TO**


**SECTION
      302 OF THE SARBANES-OXLEY ACT OF 2002**


**OF
      THE SECURITIES EXCHANGE ACT OF 1934**





I,
      Halton Martin, Chief Executive Officer and Principal Financial Officer of Vital
      Health Technologies, Inc. certifies that:





(1)
      I have reviewed this annual report on Form 10-KSB of Caribbean American Health
      Resorts, Inc.





(2)
      Based on my knowledge, this annual report does not contain any


untrue
      statement of a material fact or omit to state a material fact necessary to
      make
      the statements made, in light of the circumstances under which such statements
      were not misleading with respect to the period covered by this annual
      report.





(3)
      Based on my knowledge, the financial statements, and other financial information
      included in this annual report, fairly present in all material respects the
      financial condition, results of operations and cash flows of the registrant
      as
      of, and for, the periods presented in the report.





(4)
      I am responsible for establishing and maintaining disclosure controls and
      procedures (as defined in Exchange Act Rules 13a-14 and 15d-14) for the
      registrant and I have:





a.
      designed such disclosure controls and procedures to ensure that material
      information relating to the registrant, including its consolidated subsidiaries,
      is made known to me by others within those entities, particularly during the
      period in which this annual report is being prepared;





b.
      evaluated the effectiveness of the registrant's disclosure controls and
      procedures as of a date within 90 days prior to the filing date of this annual
      report (the "Evaluation Date"); and





c.
      presented in this annual report my conclusions about the effectiveness of the
      disclosure controls and procedures based on my evaluation as of the Evaluation
      Date.





(5)
      I have disclosed, based on the most recent evaluation, to the registrant's
      auditors and the registrant's Board of Directors:





a.
      all significant deficiencies in the design or operation of internal controls
      which could adversely affect the registrant's ability to record, process,
      summarize and report financial data and have identified for the registrant's
      auditors any material the company weaknesses in internal controls;
      and





b.
      any fraud, whether or not material, that involves management or other employees
      who have a significant role in the registrant's internal controls;
      and





I
      have
      indicated in this annual report whether or not there the company significant
      changes in internal controls or in other factors that could significantly affect
      internal controls subsequent to the date of the most recent evaluation,
      including any corrective actions with regard to significant deficiencies and
      material the company weaknesses.








/*s/
                Halton Martin*
            June
                20, 2007Halton
                MartinChief
                Executive Officer andPrincipal
                Financial Officer